OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Clinical characteristics of COVID-19 patients with underlying rheumatic diseases in Japan: data from a multicenter observational study using the COVID-19 Global Rheumatology Alliance physician-reported registry
Mari Kihara, Takahiko Sugihara, Junichi Asano, et al.
Clinical Rheumatology (2022) Vol. 41, Iss. 12, pp. 3661-3673
Open Access | Times Cited: 6
Mari Kihara, Takahiko Sugihara, Junichi Asano, et al.
Clinical Rheumatology (2022) Vol. 41, Iss. 12, pp. 3661-3673
Open Access | Times Cited: 6
Showing 6 citing articles:
Omicron variant dominance and anti-SARS-CoV-2 vaccination are key determinants for a milder course of COVID-19 in patients with systemic autoimmune rheumatic diseases
Charalampos Papagoras, Nikoleta Zioga, Vasileios Papadopoulos, et al.
Clinical Rheumatology (2023) Vol. 42, Iss. 12, pp. 3375-3385
Open Access | Times Cited: 8
Charalampos Papagoras, Nikoleta Zioga, Vasileios Papadopoulos, et al.
Clinical Rheumatology (2023) Vol. 42, Iss. 12, pp. 3375-3385
Open Access | Times Cited: 8
Managing Patients with Immune-Mediated Inflammatory Diseases on Disease-Modifying Antirheumatic Drug Therapy in a COVID-19 Endemic World: A Narrative Review and Expert Insights
Kok Ooi Kong, Pinyo Rattanaumpawan, Nguyen Chau Tuan, et al.
(2024)
Open Access | Times Cited: 1
Kok Ooi Kong, Pinyo Rattanaumpawan, Nguyen Chau Tuan, et al.
(2024)
Open Access | Times Cited: 1
The effect of COVID-19 infection on patients with rheumatic diseases in China
Peng Lai, Haifeng Chen, Yunxia Yan, et al.
Clinical Rheumatology (2024) Vol. 43, Iss. 3, pp. 1199-1206
Closed Access | Times Cited: 1
Peng Lai, Haifeng Chen, Yunxia Yan, et al.
Clinical Rheumatology (2024) Vol. 43, Iss. 3, pp. 1199-1206
Closed Access | Times Cited: 1
Prognostic improvement and treatment of COVID-19 in patients with rheumatic diseases until December 2022: Analysis of the JCR COVID-19 registry in Japan
Yusuke Kashiwado, Yasutaka Kimoto, Kenji Oku, et al.
Modern Rheumatology (2023) Vol. 34, Iss. 3, pp. 576-583
Open Access | Times Cited: 2
Yusuke Kashiwado, Yasutaka Kimoto, Kenji Oku, et al.
Modern Rheumatology (2023) Vol. 34, Iss. 3, pp. 576-583
Open Access | Times Cited: 2
Treatment patterns and clinical outcomes of immunocompromised patients with COVID-19 receiving remdesivir in the inpatient setting in Japan
Manami Yoshida, Nao Taguchi, Yi Piao, et al.
Journal of Infection and Chemotherapy (2024)
Closed Access
Manami Yoshida, Nao Taguchi, Yi Piao, et al.
Journal of Infection and Chemotherapy (2024)
Closed Access
Recent advancements in traditional Chinese medicine for COVID-19 with comorbidities across various systems: a scoping review
Xiyu Shang, Yuqing Cao, Yang Guo, et al.
Infectious Diseases of Poverty (2024) Vol. 13, Iss. 1
Open Access
Xiyu Shang, Yuqing Cao, Yang Guo, et al.
Infectious Diseases of Poverty (2024) Vol. 13, Iss. 1
Open Access
